Monday
Africa to benefit from malaria vaccine
Saturday
US approves new cholesterol drug
Praluent is the name of the new drug approved by US regulators for people with certain genetic risk factors for heart disease.
The new drug is not in oral form, it is an injectable drug, made by Sanofi and Regeneron, and it is the first of its kind to gain approval on the US market, and offers an alternative to popular pill-based statins.
However, the US Food and Drug Administration approved it only for adults with an inherited condition that predisposes them to high cholesterol and raises the risk of heart attack and stroke.
The drug is not currently available in Nigeria, but there's hope it will get to Nigeria soon.
Good news for those who says "injection better pass tablet"
Stay healthy!
Thursday
New Drug might block Malaria
Scientists have developed a new drug that shows hope for stopping deadly malaria in its track.
The new drug acts as a roadblock for malaria, curing mice of established infection, according to a study. Treatment was not associated with obvious side effects, suggesting that the drug may also be safe and effective in humans.
In 2011, a group of scientists at the Wellcome Trust Sanger Institute in the UK discovered that a human protein called basigin was required for all strains of Pf to invade red blood cells, an essential stage of the parasite’s life cycle. Antibodies that block the interaction between basigin and the parasite protein PfRH5 were known to block Pf infection in culture, and the Sanger Institute group has now developed a nontoxic anti-basigin drug (called Ab-1) that cured mice of established blood infection.
The transition of promising new drugs from mice to humans usually requires costly and time-consuming clinical trials, but the path for Ab-1 may be less arduous.
Basigin has also been implicated in the progression of certain cancers and in graft-versus-host disease in transplant patients, and drugs that block the protein have already proven safe and effective in patients and are already in clinical use.
According to the World Health Organization malaria currently infects more than 200 million people worldwide and accounts for more than 500,000 deaths per year.
Malaria has been a problem in Nigeria for centuries.
The disease is caused by infection with the parasite Plasmodium falciparum (Pf), and although the disease can be treated with anti-malarial drugs, the drugs are harsh and resistance often develops.
The study is published in the Journal of Experimental Medicine.
Monday
GRAMMATICAL ERRORS (GBAGAUN) that 'we' hate.
Sunday
HOLY BIBLE NOW IN IDOMA
The Holy Bible in Idoma language (Ubayibu K'Idoma) was unveiled today to the public during a concelebrated Mass by the Catholic Archbishop of Abuja Diocese in Nigeria
Ubayibu K‘Idoma is the first attempt to give a full translation of the entire Bible in Idoma.



